Do Not Do Recommendation

 
Do not routinely assess progesterone receptor status of tumours in patients with invasive breast cancer.

Do Not Do Recommendation Details

Recommendation:
Do not routinely assess progesterone receptor status of tumours in patients with invasive breast cancer.
Interventions:
assessment of progesterone receptor status of tumours

Source guidance details

Guidance:
Early and locally advanced breast cancer (CG80)
Published date:
February 2009
Paragraph number:
1.6.2
Page number:
15

View all NICE do not do from this Guidance